4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures

Mise à jour : Il y a 4 ans
Référence : NCT00368472

Femme et Homme

Extrait

The purpose of this study is to determine the safety of perampanel given as adjunctive, long-term treatment in patients with refractory partial onset seizures.


Critère d'inclusion

  • Epilepsy


Liens